Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 829 Records) |
Query Trace: Carcinoma and Braf[original query] |
---|
Analysis of BRAF Gene Mutation in Hashimoto's Thyroiditis With Multifocal Papillary Thyroid Carcinoma. The American surgeon 2024 9 31348241282710. Feng Wang, Yanling Su, Xiyu Yao, Jie Liu, Qingxian |
Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521. JCO global oncology 2024 9 10 e2400125. Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Ya |
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population. World journal of surgical oncology 2024 9 22 (1): 259. Rong Cong, Hui Ouyang, Di Zhou, Xinying Li, Fada X |
BRAF mutations and the association of V600E with CD133 and CDX2 expression in a Pakistani colorectal carcinoma cohort. BMC cancer 2024 9 24 (1): 1162. Sobia Hassan, Talat Mirza, Ambrina Khatoon, Uzma Bukhari, Fouzia Shaikh, Asad Kar |
Integrated molecular profiling of RAS, BRAF mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality. Journal of gastrointestinal oncology 2024 9 15 (4): 1580-1591. Gabriela Remonatto, Emily Ferreira Salles Pilar, Fernanda de-Paris, Pedro Guilherme Schaefer, Lúcia Maria Kliema |
Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements. Thyroid research 2024 9 17 (1): 21. Daisuke Uno, Kazuhira Endo, Tomomi Yoshikawa, Nobuyuki Hirai, Eiji Kobayashi, Yosuke Nakanishi, Satoru Kondo, Tomokazu Yoshiza |
Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-center Retrospective Cohort Study in a Chinese Population. Thyroid : official journal of the American Thyroid Association 2024 8 . Zhiting Wang, Qianlan Yao, Longlong Bao, Heng Chang, Min Ren, Tian Xue, Ran Wei, Chengli Yu, Qian Wang, Yu Wang, Bo Ping, Qian-Ming Bai, Xiaoyan Zhou, Xiao-Li Z |
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma. Discover oncology 2024 8 15 (1): 382. Takeshi Tsuda, Tomomi Ichikawa, Masahiro Matsumoto, Isami Mizusihima, Kenji Azechi, Naoki Takata, Nozomu Murayama, Kana Hayashi, Takahiro Hirai, Zenta Seto, Kotaro Tokui, Yasuaki Masaki, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Shingo Imanishi, Hirokazu Taniguchi, Toshiro Miwa, Ryuji Hayashi, Shoko Matsui, Minehiko Inoma |
Molecular aspects of BRAF and HER2 in prognosis of periampullary carcinoma. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2024 8 . Apurva, Nimisha, Abhay Kumar Sharma, Arun Kumar, Ejaj Ahmad, Seneha Santoshi, Sundeep Singh Salu |
BRAF-induced EHF expression affects TERT in aggressive papillary thyroid cancer. The Journal of clinical endocrinology and metabolism 2024 8 . Yiyi Xu, Jiwei Gao, Na Wang, Jan Zedenius, Inga-Lena Nilsson, Weng-Onn Lui, Dawei Xu, C Christofer Juhlin, Catharina Larsson, Ninni |
Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance. The Journal of clinical endocrinology and metabolism 2024 8 . Teresa Ramone, Arianna Ghirri, Alessandro Prete, Antonio Matrone, Raffaele Ciampi, Paolo Piaggi, Maria Scutari, Teresa Rago, Liborio Torregrossa, Cristina Romei, Rossella Elisei, Eleonora Molina |
Eosinophilic Cells in Ovarian Borderline Serous Tumors as a Predictor of BRAF Mutation. Cancers 2024 7 16 (13): . Alina Badlaeva, Anna Tregubova, Andrea Palicelli, Aleksandra Asaturo |
Prediction of the Aggressive Clinical Course of Papillary Thyroid Carcinoma Based on Fine Needle Aspiration Biopsy Molecular Testing. International journal of molecular sciences 2024 7 25 (13): . Sergei A Lukyanov, Sergei E Titov, Evgeniya S Kozorezova, Pavel S Demenkov, Yulia A Veryaskina, Denis V Korotovskii, Tatyana E Ilyina, Sergey L Vorobyev, Vladimir A Zhivotov, Nikita S Bondarev, Ilya V Sleptsov, Sergei V Sergiy |
Comprehensive analysis of gene mutations and mismatch repair in Chinese colorectal cancer patients. World journal of gastrointestinal oncology 2024 7 16 (6): 2673-2682. Huang Chen, Rui-Ying Jiang, Zhan Hua, Xiao-Wei Wang, Xiao-Li Shi, Ye Wang, Qian-Qian Feng, Jie Luo, Wu Ning, Yan-Fen Shi, Da-Kui Zhang, Bei Wang, Jian-Zheng Jie, Ding-Rong Zho |
Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108068. Mingying Wu, Na Zhou, Mei Guan, Yingyi Wang, Yuzhou Wa |
Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohort. ESMO open 2024 12 10 (1): 104090. F Camarda, L Mastrantoni, C Parrillo, A Minucci, F Persiani, D Giannarelli, T Pasciuto, F Giacomini, E De Paolis, M Manfredelli, C Marchetti, G F Zannoni, A Fagotti, G Scambia, C Ne |
PIK3CA Mutations and Co-Mutations in Operated Non-Small Cell Lung Carcinoma. Journal of clinical medicine 2024 12 13 (23): . Salih Cokpinar, Ibrahim Halil Erdogdu, Seda Orenay-Boyacioglu, Olcay Boyacioglu, Nesibe Kahraman-Cetin, Ibrahim Meteog |
The genomic landscape of papillary thyroid carcinoma on next-generation sequencing in patients undergoing total thyroidectomy. World journal of surgery 2024 11 . Karunakaran Poongkodi, Sumathi Periyasamy, Raj Ashok Gurunathan, Vijayakumar Krishnasamy, Deepak Jayakumar, Ramesh Subburaman, Sujatha Jayaraman, Sudheesh K Prabhud |
The value of NGS-based multi-gene testing for differentiation of benign from malignant and risk stratification of thyroid nodules. Frontiers in oncology 2024 11 14 1414492. Mingjian Fei, Dongdong Ding, Xuanyi Ouyang, Wenyan Shen, Fenglan Zhang, Bo Zhang, Lan Q |
Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment. European review for medical and pharmacological sciences 2024 11 28 (21): 4515-4525. Z Teke, A Bisgin, C Oruc Rencuzogullari, K Eren Erdogan, C K Parsak, S Kalkanli T |
Detection of genetic mutations in 855 cases of papillary thyroid carcinoma by next generation sequencing and its clinicopathological features. Diagnostic pathology 2024 11 19 (1): 146. Dongliang Shi, Meihong Yao, Dan Wu, Meichen Jiang, Junkang Li, Yuhui Zheng, Yinghong Ya |
Frequency of KRAS and BRAF mutations in colorectal carcinoma and their association with clinical-pathological characteristics in a tertiary hospital in Kenya. Frontiers in medicine 2024 10 11 1433120. Samuel Gakinya, Allan Njau, Abdulkarim Abdallah, Ancent Nzioka, James Ogu |
A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis: BRAF may not be a valuable predictor. Frontiers in endocrinology 2024 10 15 1429382. Yanwei Chen, Shuangshuang Zhao, Zheng Zhang, Zheming Chen, Bingxin Jiang, Maohui An, Mengyuan Shang, Xincai Wu, Xin Zhang, Baoding Ch |
Association Between Gross Features and Coexistence of BRAF and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis Incorporating Clinicopathologic Features. Thyroid : official journal of the American Thyroid Association 2024 10 . Thi Ngoc Anh Nguyen, Van Phu Thang Nguyen, Hirokazu Kurohama, Yuko Akazawa, Katsuya Matsuda, Zhanna Mussazhanova, Yuki Matsuoka, Kenichi Yokota, Shinya Satoh, Hiroyuki Yamashita, Thi Nhung Nguyen, Yerkerzhan Sailaubekova, Masahiro Nakashi |
Clinical and Histopathological Features of Thyroid Cancer with TERT Promoter Molecular Alterations in Isolation Versus with Concurrent Molecular Alterations: A Multicenter Retrospective Study. Cancers 2024 10 16 (20): . Emily Steinberg, Orr Dimitstein, Grégoire B Morand, Véronique-Isabelle Forest, Sabrina D da Silva, Marc Pusztaszeri, Sama Alohali, Richard J Pay |
CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. JAMA oncology 2024 10 . Maria E Cabanillas, Ramona Dadu, Renata Ferrarotto, Maria Gule-Monroe, Suyu Liu, Bryan Fellman, Michelle D Williams, Mark Zafereo, Jennifer R Wang, Charles Lu, Matthew Ning, Brian A McKinley, Scott E Woodman, Dzifa Duose, Gary B Gunn, Naifa L Busaidy, |
Early genetic divergence of high-grade carcinomas originating from low-grade ovarian serous neoplasms. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2024 10 100629. M Herman Chui, Qianqian Song, Jiarun Zhu, Yuchen Jiao, Brant Wang, Yeh Wang, Tian-Li Wang, Russell Vang, Ie-Ming Sh |
Influence of Body Mass Index on the Clinicopathological Features of Papillary Thyroid Carcinoma in a Chinese Population. Metabolic syndrome and related disorders 2025 1 . Li Zhang, Shichen Xu, Xian Cheng, Yun Zhu, Gangming Cai, Jing Wu, Wenjing Gao, Jiandong Bao, Huixin |
Environmental Exposures and Canine Bladder Cancer: A Case Control Study Using Silicone Passive Samplers. Environmental science & technology 2025 1 . Catherine F Wise, Nicholas J Herkert, Kate Hoffman, Shelly Vaden, Matthew Breen, Heather M Staplet |
- Page last reviewed:Feb 1, 2024
- Content source: